Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes

J Thromb Haemost. 2004 Apr;2(4):547-50. doi: 10.1111/j.1538-7933.2004.00647.x.
No abstract available

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / blood
  • Anticoagulants / therapeutic use
  • Drug Monitoring*
  • Factor Xa Inhibitors
  • Hemorrhage / etiology
  • Hemorrhage / prevention & control
  • Heparin, Low-Molecular-Weight / adverse effects
  • Heparin, Low-Molecular-Weight / blood
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Practice Guidelines as Topic*

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Heparin, Low-Molecular-Weight